MyFinsight
Home
Blog
About
BIOMERICA INC (BMRA)
BIOMERICA INC (BMRA)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$1,207K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Dividend, interest, and other in...
Share-based compensation
Amortization of right-of-use ass...
Others
Negative Cash Flow Breakdown
Cost of sales
General and administrative
Sales and marketing
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-02-28
2025-11-30
2025-08-31
2025-05-31
Net sales
3,578
-
-
-
Cost of sales
3,145
-
-
-
Gross profit (loss)
433
-
-
-
Sales and marketing
1,284
-
-
-
General and administrative
2,353
-
-
-
Research and development
583
-
-
-
Total operating expenses
4,220
-
-
-
Loss from operations
-3,787
-
-
-
Dividend, interest, and other income (loss)
1,174
-
-
-
Total other income (loss)
1,174
-
-
-
Loss before income taxes
-2,613
-
-
-
(provision) benefit for income taxes
17
-
-
-
Net loss
-1,312
-1,320
2
-4,973
Depreciation and amortization
20
20
20
87
Provision for allowance for credit losses
-59
32
38
8
Inventory reserve
-36
-44
7
4
Share-based compensation
135
117
133
460
Amortization of right-of-use assets
85
83
82
313
Accounts receivable
-64
-227
512
-209
Inventories
84
8
-10
-882
Prepaid expenses and other
24
9
-87
17
Other assets
0
-11
-5
-8
Accounts payable and accrued expenses
-12
60
10
-466
Accrued compensation
63
-47
-63
1
Advance from customers
0
-24
-1
-30
Reduction in lease liabilities
-90
-89
-86
-327
Net cash used in operating activities
-1,250
-991
-268
-3,841
Purchases of property and equipment
-
-
-
0
Expenditures related to intangible assets
19
-
-
37
Net cash used in investing activities
-19
-
-
-37
Gross proceeds from sale of common stock
63
493
939
2,143
Deferred offering costs
-
-
-
3
Costs from sale of common stock
2
11
19
44
Proceeds from exercise of stock options
-
-
-
15
Net cash provided by financing activities
61
482
920
2,111
Effect of exchange rate changes on cash
1
-1
2
-3
Net decrease in cash and cash equivalents
-1,207
-510
654
-1,770
Cash and cash equivalents at beginning of period
3,053
3,053
2,399
-
Cash and cash equivalents at end of period
1,336
2,543
3,053
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Gross proceeds from
sale of common stock
$63K
Net cash provided by
financing activities
$61K
Effect of exchange rate
changes on cash
$1K
Canceled cashflow
$2K
Net decrease in cash
and cash...
-$1,207K
Canceled cashflow
$62K
Share-based compensation
$135K
Amortization of right-of-use
assets
$85K
Accounts receivable
-$64K
Accrued compensation
$63K
Depreciation and
amortization
$20K
Costs from sale of
common stock
$2K
Net cash used in
operating activities
-$1,250K
Canceled cashflow
$367K
Net cash used in
investing activities
-$19K
something is missing
$1,318K
Dividend, interest, and
other income (loss)
$1,174K
Net loss
-$1,312K
Canceled cashflow
$1,318K
Reduction in lease
liabilities
-$90K
Inventories
$84K
Provision for allowance
for credit losses
-$59K
Inventory reserve
-$36K
Prepaid expenses and
other
$24K
Accounts payable and
accrued expenses
-$12K
Expenditures related to
intangible assets
$19K
Total other income
(loss)
$1,174K
Net sales
$3,578K
Loss before income
taxes
-$2,613K
Canceled cashflow
$1,174K
(provision) benefit for
income taxes
$17K
Gross profit (loss)
$433K
Canceled cashflow
$3,145K
Loss from operations
-$3,787K
Canceled cashflow
$433K
Cost of sales
$3,145K
Total operating
expenses
$4,220K
General and
administrative
$2,353K
Sales and marketing
$1,284K
Research and development
$583K
Buy us a coffee